CAMBRIDGE, Mass.--(BUSINESS WIRE)-- <\/p>\n
Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic diagnostic testing and analysis to routine clinical care, today announced that new data on the clinical validation and application of FoundationOne will be presented at the 14th Annual Advances in Genome Biology and Technology (AGBT) Meeting taking place February 20-23, 2013 in Marco Island, Fla. <\/p>\n
Phil Stephens, Ph.D., vice president, cancer genomics at Foundation Medicine, has been selected to give the closing address of the conference. In his remarks, Dr. Stephens will present details on the clinical experience derived from the genomic profiling of more than 1,000 tumor samples using FoundationOne. <\/p>\n
The schedule for Foundation Medicines presentations is as follows: <\/p>\n
Date & Time: Thursday, February 21, 2013 from 1:00 p.m. to 2:30 p.m. EST <\/p>\n
Title: Validation of a Million Base-pair Cancer Profiling Assay for Clinical Use <\/p>\n
Session: Poster Session <\/p>\n
Location: Poster No. 159, Collier Hall <\/p>\n
Presenter: Doron Lipson, Ph.D., Foundation Medicine <\/p>\n
Date & Time: Friday, February 22, 2013 at 7:50 p.m. EST <\/p>\n
<\/p>\n
Excerpt from:<\/p>\n
Foundation Medicine to Present New Data on FoundationOne\u2122, a Comprehensive Cancer Genomic Assay, at the 14th Annual ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic diagnostic testing and analysis to routine clinical care, today announced that new data on the clinical validation and application of FoundationOne will be presented at the 14th Annual Advances in Genome Biology and Technology (AGBT) Meeting taking place February 20-23, 2013 in Marco Island, Fla. Phil Stephens, Ph.D., vice president, cancer genomics at Foundation Medicine, has been selected to give the closing address of the conference. In his remarks, Dr Continue reading